Evidence map›Paper›PMID 12417669›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2002

Developmental regulation of neurotransmitter phenotype through tetrahydrobiopterin.

Beth A Habecker, Michael G Klein, Nathan C Sundgren, Wei Li, William R Woodward

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. p38α and p38β mitogen-activated protein kinases determine cholinergic transdifferentiation of sympathetic neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  3. Article
  4. Aging and the control of human skin blood flow.Frontiers in bioscience (Landmark edition) · 2010
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Beth A HabeckerDepartment of Physiology and Pharmacology, Oregon Health and Sciences University School of Medicine, Portland, Oregon 97239, USA. habecker@ohsu.edu
Michael G Klein
Nathan C Sundgren
Wei Li
William R Woodward
Oregon Health & Science University · US

Funding

Regulation of Sympathetic Function by InfarctionR01HL068231 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI HABECKER, BETH A · 2001 to 2015
$4.3M
NHLBI NIH HHS HL68231NHLBI NIH HHS R01 HL068231
6 · The paper itself

Abstract

During development, sympathetic neurons innervating rodent sweat glands undergo a target-induced change in neurotransmitter phenotype from noradrenergic to cholinergic. Although the sweat gland innervation in the adult mouse is cholinergic and catecholamines are absent, these neurons continue to express tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis. The developmental suppression of noradrenergic function in these mouse sympathetic neurons is not well understood. We investigated whether the downregulation of the enzyme aromatic l-amino acid decarboxylase (AADC) or the TH cofactor tetrahydrobiopterin (BH4) could account for the loss of catecholamines in these neurons. AADC levels did not decrease during development, and adult cholinergic sympathetic neurons were strongly immunoreactive for AADC. In contrast, BH4 levels dropped significantly in murine sweat gland-containing footpads during the time period when the gland innervation was switching from making norepinephrine to acetylcholine. Immunoreactivity for the rate-limiting BH4 synthetic enzyme GTP cyclohydrolase (GCH) became undetectable in the sweat gland neurons during this phenotypic conversion, suggesting that sweat glands reduce BH4 levels by suppressing GCH expression during development. Furthermore, extracts from sweat gland-containing footpads suppressed BH4 in cultured mouse sympathetic neurons, and addition of the BH4 precursor sepiapterin rescued catecholamine production in neurons treated with footpad extracts. Together, these results suggest that the mouse sweat gland-derived cholinergic differentiation factor functionally suppresses the noradrenergic phenotype during development by inhibiting production of the TH cofactor, BH4. These data also indicate that GCH expression, which is often coordinately regulated with TH expression, can be controlled independently of TH during development.

Indexed as

PterinsAcetylcholineAgingAnimalsAromatic-L-Amino-Acid DecarboxylasesBiopterinsBlotting, WesternCatecholaminesCells, CulturedCiliary Neurotrophic FactorDopamineFootMiceNeuronsNeurotransmitter AgentsNorepinephrineAcetylcholineAromatic-L-Amino-Acid DecarboxylasesBiopterinsCatecholaminesCiliary Neurotrophic FactorDopamineNeurotransmitter AgentsNorepinephrinePteridinesPterinssapropterinsepiapterinTissue ExtractsTyrosine 3-Monooxygenase

Identifiers

PMID12417669
PMCPMC6758055
OpenAlexW2124874936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.